- Home
- WYHG vs PACB Comparison
WYHG vs PACB Comparison
Compare WYHG & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYHG
- PACB
- Stock Information
- Founded
- WYHG 1915
- PACB 2000
- Country
- WYHG China
- PACB United States
- Employees
- WYHG N/A
- PACB N/A
- Industry
- WYHG
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- WYHG
- PACB Industrials
- Exchange
- WYHG NYSE
- PACB Nasdaq
- Market Cap
- WYHG 362.4M
- PACB 364.2M
- IPO Year
- WYHG 2024
- PACB 2010
- Fundamental
- Price
- WYHG $1.60
- PACB $1.00
- Analyst Decision
- WYHG
- PACB Buy
- Analyst Count
- WYHG 0
- PACB 9
- Target Price
- WYHG N/A
- PACB $2.34
- AVG Volume (30 Days)
- WYHG 641.2K
- PACB 9.8M
- Earning Date
- WYHG 06-10-2025
- PACB 05-08-2025
- Dividend Yield
- WYHG N/A
- PACB N/A
- EPS Growth
- WYHG N/A
- PACB N/A
- EPS
- WYHG 0.20
- PACB N/A
- Revenue
- WYHG $147,996,867.00
- PACB $152,357,000.00
- Revenue This Year
- WYHG N/A
- PACB $4.01
- Revenue Next Year
- WYHG N/A
- PACB $18.54
- P/E Ratio
- WYHG $4.98
- PACB N/A
- Revenue Growth
- WYHG 9.62
- PACB N/A
- 52 Week Low
- WYHG $1.12
- PACB $0.85
- 52 Week High
- WYHG $12.00
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- WYHG N/A
- PACB 44.98
- Support Level
- WYHG N/A
- PACB $0.85
- Resistance Level
- WYHG N/A
- PACB $1.10
- Average True Range (ATR)
- WYHG 0.00
- PACB 0.09
- MACD
- WYHG 0.00
- PACB 0.01
- Stochastic Oscillator
- WYHG 0.00
- PACB 50.00
About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD
Wing Yip Food Holdings Group Ltd is a meat producer. The company is mainly engaged in offering ready to eat and packaged meat dishes. Its product offerings include supreme crispy sausage, fully thin sausage, Chinese sausage, Dongguan Erba sausage, yellow scorpion sausage, alcohol sausage, and meat chop.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.